| abstract |
IT REFERS TO A PHARMACEUTICAL PREPARATION THAT INCLUDES: A) SELECTED PROGESTIN FROM LEVONORGESTREL, NORGESTIMATE, NORETISTERONE, AMONG OTHERS; B) ESTROGEN SELECTED FROM ETHINYLESTRADIOL, MESTRANOL, QUINESTRANOL, AMONG OTHERS, TO OBTAIN A HORMONAL TREATMENT THAT CONSISTS OF A FIRST COMPOSITION ADMINISTERED IN THE FIRST 21 TO 28 DAYS AND A SECOND COMPOSITION OF A MISCELLANEOUS MONEY OR MISCELLANEOUS SEQUENCE. WHERE THE HORMONES CONTAINED ARE FOUND IN GREATER QUANTITIES THAN IN THE FIRST COMPOSITION. THE ADMINISTRATION OF THE FIRST AND SECOND COMPOSITION IS EXTENDED FOR A PERIOD OF 56, 84, 112, 140, 168 DAYS ALLOWING TO OBTAIN A CONTINUOUS STIMULATION OF THE ENDOMETRY |